Yonggang Liang, Yanchao Xu, Megan Virostek, Ann Johnson, Bret Evers, Yaqin Deng, Yawen Meng, Jeffrey G McDonald, Philipp E Scherer, Shaojie Cui, Jin Ye
{"title":"Advanced Alcoholic Liver Disease Driven by a Pro-ferroptotic Diet.","authors":"Yonggang Liang, Yanchao Xu, Megan Virostek, Ann Johnson, Bret Evers, Yaqin Deng, Yawen Meng, Jeffrey G McDonald, Philipp E Scherer, Shaojie Cui, Jin Ye","doi":"10.1016/j.jlr.2025.100898","DOIUrl":null,"url":null,"abstract":"<p><p>Alcoholic liver disease (ALD) encompasses a spectrum of disorders, with advanced ALD-characterized by liver fibrosis-representing a severe stage with high mortality. The NIAAA ALD mouse model, a classical approach to study ALD by delivering alcohol through the Lieber-Decarli (LD) diet, typically does not progress to advanced ALD. We previously determined that ferroptosis causes hepatocellular injury in this model. Here we speculate that the enrichment of monounsaturated fatty acids (MUFAs) and vitamin E, which inhibit ferroptosis, and the lack of the pro-ferroptotic nutrient iron in the LD diet, may limit the progression of ALD by inhibiting ferroptosis. To test this hypothesis, we modified the LD diet to generate a pro-ferroptotic LD (PFLD) diet by depleting vitamin E, increasing dietary levels of iron, and replacing MUFAs with polyunsaturated fatty acids (PUFAs) that drive ferroptosis. Upon feeding alcohol through the PFLD diet, ∼30% of the mice developed liver fibrosis and macrosteatosis, hallmarks of advanced ALD. These pathological changes were associated with exacerbated ferroptosis, possibly driven by overaccumulation of PUFA-containing triglycerides. Our findings underscore the critical role of dietary lipid composition in determining ALD severity, and demonstrate that feeding alcohol through the PFLD diet may serve as a mouse model for advanced ALD.</p>","PeriodicalId":16209,"journal":{"name":"Journal of Lipid Research","volume":" ","pages":"100898"},"PeriodicalIF":4.1000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Lipid Research","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jlr.2025.100898","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Alcoholic liver disease (ALD) encompasses a spectrum of disorders, with advanced ALD-characterized by liver fibrosis-representing a severe stage with high mortality. The NIAAA ALD mouse model, a classical approach to study ALD by delivering alcohol through the Lieber-Decarli (LD) diet, typically does not progress to advanced ALD. We previously determined that ferroptosis causes hepatocellular injury in this model. Here we speculate that the enrichment of monounsaturated fatty acids (MUFAs) and vitamin E, which inhibit ferroptosis, and the lack of the pro-ferroptotic nutrient iron in the LD diet, may limit the progression of ALD by inhibiting ferroptosis. To test this hypothesis, we modified the LD diet to generate a pro-ferroptotic LD (PFLD) diet by depleting vitamin E, increasing dietary levels of iron, and replacing MUFAs with polyunsaturated fatty acids (PUFAs) that drive ferroptosis. Upon feeding alcohol through the PFLD diet, ∼30% of the mice developed liver fibrosis and macrosteatosis, hallmarks of advanced ALD. These pathological changes were associated with exacerbated ferroptosis, possibly driven by overaccumulation of PUFA-containing triglycerides. Our findings underscore the critical role of dietary lipid composition in determining ALD severity, and demonstrate that feeding alcohol through the PFLD diet may serve as a mouse model for advanced ALD.
期刊介绍:
The Journal of Lipid Research (JLR) publishes original articles and reviews in the broadly defined area of biological lipids. We encourage the submission of manuscripts relating to lipids, including those addressing problems in biochemistry, molecular biology, structural biology, cell biology, genetics, molecular medicine, clinical medicine and metabolism. Major criteria for acceptance of articles are new insights into mechanisms of lipid function and metabolism and/or genes regulating lipid metabolism along with sound primary experimental data. Interpretation of the data is the authors’ responsibility, and speculation should be labeled as such. Manuscripts that provide new ways of purifying, identifying and quantifying lipids are invited for the Methods section of the Journal. JLR encourages contributions from investigators in all countries, but articles must be submitted in clear and concise English.